Untreated glioblastoma multiforme: Increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy

Radiology

Volumn 253, Issue 3, 2009, Pages 805-812

  Kallenberg, Kai ^a   Bock, Hans C ^a   Helms, Gunther ^a   Jung, Klaus ^a   Wrede, Arne ^a   Buhk, Jan Hendrik ^a   Giese, Alf ^a   Frahm, Jens ^b   Strik, Herwig ^a   Dechent, Peter ^a   Knauth, Michael ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXA RATIOPHARM; DEXAMETHASONE; GLUTAMINE; INOSITOL; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CELL INFILTRATION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GLIOBLASTOMA; GLIOMA; GROUPS BY AGE; HEMISPHERE; HUMAN; IMAGING SYSTEM; IN VIVO STUDY; INFORMED CONSENT; MALE; METABOLITE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PROTON NUCLEAR MAGNETIC RESONANCE; THREE DIMENSIONAL IMAGING; BRAIN TUMOR; CASE CONTROL STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GLIOBLASTOMA; GLUTAMINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 73949133915     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2533071654     Document Type: Article

References (36)

1. Gallego JM, Barcia JA, Barcia-Marino C. Fatal outcome related to carmustine implants in glioblastoma multiforme. Acta Neurochir (Wien) 2007;149:261-265.
2. Matsukado Y, Maccarty CS, Kernohan JW. The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. J Neurosurg 1961;18:636-644.
3. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987;66:865-874.
4. Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34:463-469.
5. Silbergeld DL, Chicoine MR. Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 1997;86:525-531.
6. de Bouard S, Christov C, Guillamo JS, et al. Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysis. J Neurosurg 2002;97:169-176.
7. Kageji T, Nagahiro S, Uyama S, et al. Histopathological findings in autopsied glioblastoma patients treated by mixed neutron beam BNCT. J Neurooncol 2004;68:25-32.
8. Howe FA, Opstad KS. 1H MR spectroscopy of brain tumours and masses. NMR Biomed 2003;16:123-131.
9. Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992;24:123-136.
10. Frahm J, Michaelis T, Merboldt KD, Bruhn H, Gyngell ML, Hänicke W. Improvements in localized proton NMR spectroscopy of human brain: water suppression, short echo times, and 1 ml resolution. J Magn Reson 1990;90:464-473.
11. Natt O, Bezkorovaynyy V, Michaelis T, Frahm J. Use of phased array coils for a determination of absolute metabolite concentrations. Magn Reson Med 2005;53:3-8.
12. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260-264.
13. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289-298.
14. Jansen JF, Backes WH, Nicolay K, Kooi ME. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006;240:318-332.
15. Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-799.
16. McBride DQ, Miller BL, Nikas DL, et al. Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 1995;44:137-144.
17. Nelson SJ, Huhn S, Vigneron DB, et al. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. J Magn Reson Imaging 1997;7:1146-1152.
18. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB. Stereotactic histologic correlations of computed tomographyand magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450-459.
19. Cohen BA, Knopp EA, Rusinek H, Babb JS, Zagzag D, Gonen O. Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy. AJNR Am J Neuroradiol 2005;26:2170-2177.
20. Inglese M, Brown S, Johnson G, Law M, Knopp E, Gonen O. Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: a preliminary study. AJNR Am J Neuroradiol 2006;27:2137-2140.
21. Kimura T, Ohkubo M, Igarashi H, Kwee IL, Nakada T. Increase in glutamate as a sensitive indicator of extracellular matrix integrity in peritumoral edema: a 3.0-tesla proton magnetic resonance spectroscopy study. J Neurosurg 2007;106:609-613.
22. Kovacevic Z, Jerance D, Brkljac O. The role of glutamine oxidation and the purine nucleotide cycle for adaptation of tumour energetics to the transition from the anaerobic to the aerobic state. Biochem J 1988;252:381-386.
23. Kovacevic Z, Brkljac O, Bajin K. Control and function of the transamination pathways of glutamine oxidation in tumour cells. Biochem J 1991;273:271-275.
24. Kovacevic Z, Brkljac O, Jerance D. Mechanism and control of degradation and resynthesis of adenylates in tumour cells. Biochem J 1991;273:277-281.
25. McKeehan WL. Glycolysis, glutaminolysis and cell proliferation. Cell Biol Int Rep 1982;6:635-650.
26. Medina MA, Sanchez-Jimenez F, Marquez J, Rodriguez Quesada A, Nunez de Castro I. Relevance of glutamine metabolism to tumor cell growth. Mol Cell Biochem 1992;113:1-15.
27. Kotitschke K, Jung H, Nekolla S, Haase A, Bauer A, Bogdahn U. High-resolution one- and two-dimensional 1H MRS of human brain tumor and normal glial cells. NMR Biomed 1994;7:111-120.
28. Souba WW. Glutamine and cancer. Ann Surg 1993;218:715-728.
29. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
30. Sorour O, Raafat M, El-Bolkainy N, Rifaat M. Infiltrative potentiality of brain tumors in organ culture. J Neurosurg 1975;43:742-749.
31. Edvardsen K, Pedersen PH, Bjerkvig R, et al. Transfection of glioma cells with the neuralcell adhesion molecule NCAM: effect on glioma-cell invasion and growth in vivo. Int J Cancer 1994;58:116-122.
32. Andersen C. The effect of glucocorticoids in the normal cerebral hemisphere of brain tumour patients. Acta Neurol Scand 1998;98:433-438.
33. Steens SC, Steup-Beekman GM, Bosma GP, et al. The effect of corticosteroid medication on quantitative MR parameters of the brain. AJNR Am J Neuroradiol 2005;26:2475-2480.
34. Michaelis T, Merboldt KD, Bruhn H, Hänicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-227.
35. Kreis R. Quantitative localized 1H MR spectroscopy for clinical use. Prog NMR Spectroscopy 1997;31:155-195.
36. Pouwels PJ, Brockmann K, Kruse B, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999;46:474-485.